Use of dexmedetomidine for sedation in mechanically ventilated adult ICU patients: a rapid practice guideline
- PMID: 35587274
- DOI: 10.1007/s00134-022-06660-x
Use of dexmedetomidine for sedation in mechanically ventilated adult ICU patients: a rapid practice guideline
Abstract
Purpose: The aim of this Intensive Care Medicine Rapid Practice Guideline (ICM‑RPG) was to formulate evidence‑based guidance for the use of dexmedetomidine for sedation in invasively mechanically ventilated adults in the intensive care unit (ICU).
Methods: We adhered to the methodology for trustworthy clinical practice guidelines, including use of the Grading of Recommendations Assessment, Development, and Evaluation approach to assess the certainty of evidence, and the Evidence-to-Decision framework to generate recommendations. The guideline panel comprised 28 international panelists, including content experts, ICU clinicians, methodologists, and patient representatives. Through teleconferences and web‑based discussions, the panel provided input on the balance and magnitude of the desirable and undesirable effects, the certainty of evidence, patients' values and preferences, costs and resources, feasibility, acceptability, and research priorities.
Results: The ICM‑RPG panel issued one weak recommendation (suggestion) based on overall moderate certainty of evidence: "In invasively mechanically ventilated adult ICU patients, we suggest using dexmedetomidine over other sedative agents, if the desirable effects including a reduction in delirium are valued over the undesirable effects including an increase in hypotension and bradycardia".
Conclusion: This ICM-RPG provides updated evidence-based guidance on the use of dexmedetomidine for sedation in mechanically ventilated adults, and outlines uncertainties and research priorities.
Keywords: Clinical practice guideline; Dexmedetomidine; ICM-RPG; Sedation.
© 2022. Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Reade MC, Finfer S (2014) Sedation and delirium in the intensive care unit. N Engl J Med 370:444–454. https://doi.org/10.1056/NEJMra1208705 - DOI - PubMed
-
- Zaal IJ, Devlin JW, Peelen LM, Slooter AJC (2015) A systematic review of risk factors for delirium in the ICU*. Crit Care Med 43:40–47. https://doi.org/10.1097/CCM.0000000000000625 - DOI - PubMed
-
- Devlin JW, Skrobik Y, Gélinas C et al (2018) Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med 46:e825–e873. https://doi.org/10.1097/CCM.0000000000003299 - DOI - PubMed
-
- Duprey MS, Dijkstra-Kersten SMA, Zaal IJ et al (2021) Opioid use increases the risk of delirium in critically Ill adults independently of pain. Am J Respir Crit Care Med 204:566–572. https://doi.org/10.1164/rccm.202010-3794OC - DOI - PubMed
-
- Weerink MAS, Struys MMRF, Hannivoort LN et al (2017) Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine. Clin Pharmacokinet 56:893–913. https://doi.org/10.1007/s40262-017-0507-7 - DOI - PubMed - PMC
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
